Ropes & Gray has advised certain selling shareholders on the sale of Quotient Sciences, a UK-headquartered provider of outsourced drug development services, to Permira, a global private equity firm.
Quotient Sciences provides drug development, commercial and manufacturing services to the pharmaceutical and biotech industries. The company, which generates more than £100m in revenues, has more than 850 employees across six operating sites in the UK and US.
The Ropes & Gray team was led by private equity partner Helen Croke, with private equity associate Kenan Ceylan, both based in London.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.